Wright D H, Nantel F, Metters K M, Ford-Hutchinson A W
Department of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
Eur J Pharmacol. 1999 Jul 14;377(1):101-15. doi: 10.1016/s0014-2999(99)00358-1.
We report the cloning, functional expression and cell-specific localization of the rat homologue of the prostaglandin D2 receptor (DP). In situ hybridization, utilizing multiple digoxigenin-labelled riboprobes and their complementary sense controls, was performed to determine the detailed distribution of DP receptor mRNA in the central nervous system and the gastrointestinal tract. Within the brain, the leptomeninges and choroid plexus expressed DP receptor mRNA. Transcripts detected in the spinal cord were localized to the sensory and motor neurons of the dorsal and ventral horns, respectively, suggesting a role for the DP receptor in the modulation of central nervous system processes, including pain transmission. Within the gastrointestinal tract (stomach, duodenum, ileum and colon) signals were highly localized to the mucous-secreting goblet cells and the columnar epithelium. These findings suggest a novel biological role for prostaglandin D2-mediated activity at the DP receptor, namely mucous secretion. In addition, radioligand binding assays (saturation analyses and equilibrium competition assays) and functional assays (measuring cAMP accumulation) were performed to characterize the recombinant rat DP receptor expressed in human embryonic kidney (HEK) 293(EBNA) cells. A single site of binding (K(D) = 14 nM, Bmax = 115 fmol/mg protein) was measured for prostaglandin D2-specific binding to the rat DP receptor. Prostaglandin D2 proved to be a potent agonist at the rat DP receptor (EC50 = 5 nM). The rank order of efficacy for DP receptor specific agonists [prostaglandin D2 = prostaglandin J2 = BW 245C (5-(6-carboxyhexyl)-1-(3-cyclohexyl-3-hydroxypropylhydantoin)) > L-644,698 ((4-(3-(3-(3-hydroxyoctyl)-4-oxo-2-thiazolidinyl) propyl) benzoic acid) (racemate)] reflected the affinity with which the ligands bound to the receptor.
我们报告了前列腺素D2受体(DP)大鼠同源物的克隆、功能表达及细胞特异性定位。利用多种地高辛标记的核糖探针及其互补正义对照进行原位杂交,以确定DP受体mRNA在中枢神经系统和胃肠道中的详细分布。在脑内,软脑膜和脉络丛表达DP受体mRNA。在脊髓中检测到的转录本分别定位于背角和腹角的感觉神经元和运动神经元,提示DP受体在调节包括疼痛传递在内的中枢神经系统过程中发挥作用。在胃肠道(胃、十二指肠、回肠和结肠)内,信号高度定位于分泌黏液的杯状细胞和柱状上皮。这些发现提示前列腺素D2在DP受体介导的活性中具有一种新的生物学作用,即黏液分泌。此外,进行了放射性配体结合试验(饱和分析和平衡竞争试验)和功能试验(测量cAMP积累),以表征在人胚肾(HEK)293(EBNA)细胞中表达的重组大鼠DP受体。测定了前列腺素D2与大鼠DP受体特异性结合的单个结合位点(K(D)=14 nM,Bmax=115 fmol/mg蛋白)。前列腺素D2被证明是大鼠DP受体的有效激动剂(EC50=5 nM)。DP受体特异性激动剂的效能排序[前列腺素D2 = 前列腺素J2 = BW 245C(5-(6-羧基己基)-1-(3-环己基-3-羟丙基乙内酰脲))> L-644,698((4-(3-(3-(3-羟基辛基)-4-氧代-2-噻唑烷基)丙基)苯甲酸)(外消旋体)]反映了配体与受体结合的亲和力。